Accessing rare activities from random RNA sequences: the importance of the length of molecules in the starting pool.

BACKGROUND In the past few years numerous binding and catalytic motifs have been isolated from pools of random nucleic acid sequences. To extend the utility of this approach it is important to learn how to design random-sequence pools that provide maximal access to rare activities. In an effort to better define the relative merits of longer and shorter pools (i.e. pools with longer or shorter random-sequence segments), we have examined the inhibitory effect of excess arbitrary sequence on ribozyme activity and have evaluated whether this inhibition overshadows the calculated advantage of longer pools. RESULTS The calculated advantage of longer sequences was highly dependent on the size and complexity of the desired motif. Small, simple motifs were not much more abundant in longer molecules. In contrast, larger motifs, particularly the most complex (highly modular) motifs, were much more likely to be present in longer molecules. The experimentally determined inhibition of activity by excess sequence was moderate, with bulk effects among four libraries ranging from no effect to 18-fold inhibition. The median effect among 60 clones was fivefold inhibition. CONCLUSIONS For accessing simple motifs (e.g. motifs at least as small and simple as the hammerhead ribozyme motif), longer pools have little if any advantage. For more complex motifs, the inhibitory effect of excess sequence does not approach the calculated advantage of pools of longer molecules. Thus, when seeking to access rare activities, the length of typical random-sequence pools (< or = 70 random positions) is shorter than optimal. As this conclusion holds over a range of incubation conditions, it may also be relevant when considering the emergence of new functional motifs during early evolution.

[1]  Andrew D. Ellington,et al.  Nucleic Acid Selection and the Challenge of Combinatorial Chemistry. , 1997, Chemical reviews.

[2]  J W Szostak,et al.  Structurally complex and highly active RNA ligases derived from random RNA sequences. , 1995, Science.

[3]  M Yarus,et al.  Three small ribooligonucleotides with specific arginine sites. , 1993, Biochemistry.

[4]  D. Bartel,et al.  In Vitro Selection of Catalytic RNA , 1996 .

[5]  O. Uhlenbeck,et al.  Keeping RNA happy. , 1995, RNA.

[6]  Michael Famulok,et al.  Molecular Recognition of Amino Acids by RNA-Aptamers: An L-Citrulline Binding RNA Motif and Its Evolution into an L-Arginine Binder , 1994 .

[7]  D. Bartel,et al.  Isolation of new ribozymes from a large pool of random sequences [see comment]. , 1993, Science.

[8]  Jack W. Szostak,et al.  An RNA motif that binds ATP , 1993, Nature.

[9]  A. Crameri,et al.  10(20)-fold aptamer library amplification without gel purification. , 1993, Nucleic acids research.

[10]  Ronald R. Breaker,et al.  In Vitro Selection of Catalytic Polynucleotides. , 1997, Chemical reviews.

[11]  M Yarus,et al.  Diversity of oligonucleotide functions. , 1995, Annual review of biochemistry.

[12]  L. Gold,et al.  Selection of high affinity RNA ligands to the bacteriophage R17 coat protein. , 1992, Journal of molecular biology.

[13]  Jon R. Lorsch,et al.  In vitro evolution of new ribozymes with polynucleotide kinase activity , 1994, Nature.

[14]  Michael R. Green,et al.  HIV-1 rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA , 1991, Cell.

[15]  D. Bartel,et al.  The secondary structure and sequence optimization of an RNA ligase ribozyme. , 1995, Nucleic acids research.

[16]  P. Hraber,et al.  Global similarities in nucleotide base composition among disparate functional classes of single-stranded RNA imply adaptive evolutionary convergence. , 1996, RNA.

[17]  D. Herschlag RNA Chaperones and the RNA Folding Problem (*) , 1995, The Journal of Biological Chemistry.

[18]  L. Kay,et al.  α Helix-RNA Major Groove Recognition in an HIV-1 Rev Peptide-RRE RNA Complex , 1996, Science.

[19]  D. Mckay Three-Dimensional Structure of the Hammerhead Ribozyme , 1996 .